Cargando…

Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS

PURPOSE: The role of obesity in glioblastoma remains unclear, as previous analyses have reported contradicting results. Here, we evaluate the prognostic impact of obesity in two trial populations; CeTeG/NOA-09 (n = 129) for MGMT methylated glioblastoma patients comparing temozolomide (TMZ) to lomust...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weller, Johannes, Schäfer, Niklas, Schaub, Christina, Potthoff, Anna-Laura, Steinbach, Joachim P., Schlegel, Uwe, Sabel, Michael, Hau, Peter, Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Pietsch, Torsten, Tzaridis, Theophilos, Zeyen, Thomas, Borger, Valeri, Güresir, Erdem, Vatter, Hartmut, Herrlinger, Ulrich, Schneider, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325931/ https://www.ncbi.nlm.nih.gov/pubmed/35704157 http://dx.doi.org/10.1007/s11060-022-04046-z

Ejemplares similares

Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses
por: Zeyen, Thomas, et al.
Publicado: (2023)

Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses
por: Zeyen, Thomas, et al.
Publicado: (2023)

Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial
por: Weller, J., et al.
Publicado: (2023)

The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial
por: Weller, Johannes, et al.
Publicado: (2023)

Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial
por: Zeyen, Thomas, et al.
Publicado: (2022)

Lomustine and temozolomide for newly diagnosed glioblastoma with methylated MGMT promoter: Lessons from the CeTeG/NOA-09 trial
por: Tremont-Lukats, Ivo W., et al.
Publicado: (2019)

Outcome of Tumor-Associated Proptosis in Patients With Spheno-Orbital Meningioma: Single-Center Experience and Systematic Review of the Literature
por: Schneider, Matthias, et al.
Publicado: (2020)

Commentary: Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
por: Das, Sunit, et al.
Publicado: (2020)

Safety metric profiling in surgery for temporal glioblastoma: lobectomy as a supra-total resection regime preserves perioperative standard quality rates
por: Schneider, Matthias, et al.
Publicado: (2020)

Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection
por: Borger, Valeri, et al.
Publicado: (2021)

Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survival
por: Schneider, Matthias, et al.
Publicado: (2020)

The Impact of Prolonged Mechanical Ventilation on Overall Survival in Patients With Surgically Treated Brain Metastases
por: Schuss, Patrick, et al.
Publicado: (2021)

Prognostic Value of Preoperative Inflammatory Markers in Melanoma Patients with Brain Metastases
por: Schneider, Matthias, et al.
Publicado: (2021)

Tumor-associated epilepsy in patients with brain metastases: necrosis-to-tumor ratio forecasts postoperative seizure freedom
por: Bahna, Majd, et al.
Publicado: (2021)

Unplanned intensive care unit readmission after surgical treatment in patients with newly diagnosed glioblastoma — forfeiture of surgically achieved advantages?
por: Lehmann, Felix, et al.
Publicado: (2023)

Distress in Neuro-Oncology Patients and Its Implications for Communication
por: Roos, Carolin, et al.
Publicado: (2023)

Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannoma
por: Wach, Johannes, et al.
Publicado: (2021)

Postoperative Prolonged Mechanical Ventilation in Patients With Newly Diagnosed Glioblastoma—An Unrecognized Prognostic Factor
por: Schuss, Patrick, et al.
Publicado: (2020)

Perioperative red blood cell transfusion is associated with poor functional outcome and overall survival in patients with newly diagnosed glioblastoma
por: Schneider, Matthias, et al.
Publicado: (2021)

NOAS
por: Mulder, Henk
Publicado: (1997)

NOAS
por: Mulder, Henk
Publicado: (1997)

NOAS
por: Mulder, H
Publicado: (1997)

NOAS
por: Mulder, H
Publicado: (1996)

Preoperative Metastatic Brain Tumor-Associated Intracerebral Hemorrhage Is Associated With Dismal Prognosis
por: Hamed, Motaz, et al.
Publicado: (2021)

Survival in patients with surgically treated brain metastases: does infratentorial location matter?
por: Hamed, Motaz, et al.
Publicado: (2023)

Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic Signature
por: Tzaridis, Theophilos, et al.
Publicado: (2020)

Inhibition of Intercellular Cytosolic Traffic via Gap Junctions Reinforces Lomustine-Induced Toxicity in Glioblastoma Independent of MGMT Promoter Methylation Status
por: Schneider, Matthias, et al.
Publicado: (2021)

Impact of Levetiracetam Treatment on 5-Aminolevulinic Acid Fluorescence Expression in IDH1 Wild-Type Glioblastoma
por: Wach, Johannes, et al.
Publicado: (2022)

Incurring detriments of unplanned readmission to the intensive care unit following surgery for brain metastasis
por: Schweppe, Justus August, et al.
Publicado: (2023)

Red blood cell distribution width to platelet ratio substantiates preoperative survival prediction in patients with newly-diagnosed glioblastoma
por: Schneider, Matthias, et al.
Publicado: (2021)

Outcome of Elderly Patients With Surgically Treated Brain Metastases
por: Heimann, Muriel, et al.
Publicado: (2021)

Mean Platelet Volume/Platelet Count Ratio and Risk of Progression in Glioblastoma
por: Wach, Johannes, et al.
Publicado: (2021)

Rapid closure technique in suboccipital decompression
por: Vychopen, Martin, et al.
Publicado: (2021)

Complete hemispheric exposure vs. superior sagittal sinus sparing craniectomy: incidence of shear-bleeding and shunt-dependency
por: Vychopen, Martin, et al.
Publicado: (2021)

Experimental Induction of Intracranial Aneurysms in Rats: A New Model Utilizing a Genetic Modification within the EDNRA Gene
por: Lampmann, Tim, et al.
Publicado: (2022)

NOAS -02 Minutes
por: Bouthéon, M
Publicado: (1990)

NOAS Minutes - 05
Publicado: (1989)

NOAS - 01 minutes
por: Elena, M, et al.
Publicado: (1989)

Noa visiting the CCC
por: Traczyk, Piotr
Publicado: (2022)

Preoperative Risk Stratification of Increased MIB-1 Labeling Index in Pituitary Adenoma: A Newly Proposed Prognostic Scoring System
por: Maiseyeu, Ivan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jdvsb02umkgmq63bttub1bu2pq